These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
23. Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation. Rigden JP; Cornetta K; Srour EF; Hanna M; Broun ER; Hromas R; Baute J; Hilton J; Cox E; Rubin L; Gonin R; Tricot G Bone Marrow Transplant; 1996 Nov; 18(5):913-9. PubMed ID: 8932845 [TBL] [Abstract][Full Text] [Related]
24. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Barrett AJ; Mavroudis D; Tisdale J; Molldrem J; Clave E; Dunbar C; Cottler-Fox M; Phang S; Carter C; Okunnieff P; Young NS; Read EJ Bone Marrow Transplant; 1998 Mar; 21(6):543-51. PubMed ID: 9543057 [TBL] [Abstract][Full Text] [Related]
25. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498 [TBL] [Abstract][Full Text] [Related]
26. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185 [TBL] [Abstract][Full Text] [Related]
27. Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant. Godder KT; Mehta J; Chiang KY; Adams S; van Rhee F; Singhal S; Higgins-Smith K; O'Neal W; DeRienzo S; Henslee-Downey JP Bone Marrow Transplant; 2001 Dec; 28(11):1031-6. PubMed ID: 11781612 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531 [TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [TBL] [Abstract][Full Text] [Related]
30. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Kröger N; Krüger W; Wacker-Backhaus G; Hegewisch-Becker S; Stockschläder M; Fuchs N; Rüssmann B; Renges H; Dürken M; Bielack S; de Wit M; Schuch G; Bartels H; Braumann D; Kuse R; Kabisch H; Erttmann R; Zander AR Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263 [TBL] [Abstract][Full Text] [Related]
31. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
32. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120 [TBL] [Abstract][Full Text] [Related]
34. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR; Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [TBL] [Abstract][Full Text] [Related]
36. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study. Fleming DR; Henslee-Downey PJ; Romond EH; Harder EJ; Marciniak E; Munn RK; Messino MJ; Macdonald JS; Bishop M; Rayens MK; Thompson JS; Foon KA Bone Marrow Transplant; 1996 Jun; 17(6):917-22. PubMed ID: 8807094 [TBL] [Abstract][Full Text] [Related]
37. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008 [TBL] [Abstract][Full Text] [Related]
38. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center]. Schmitz N; Kayser W; Gassmann W; Euler HH; Wüstemann M; Brix F; Dühmke E; Hebbinghaus D; Gremmel H; Schaub J Dtsch Med Wochenschr; 1985 Sep; 110(39):1488-93. PubMed ID: 3896727 [TBL] [Abstract][Full Text] [Related]
39. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bunin NJ; Casper JT; Lawton C; Murray K; Camitta BM; Greenwood M; Geil J; Ash RC Bone Marrow Transplant; 1992 Feb; 9(2):119-22. PubMed ID: 1571710 [TBL] [Abstract][Full Text] [Related]
40. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Talano JM; Casper JT; Camitta BM; Keever-Taylor CA; Murray KJ; Eapen M; Pierce KL; Margolis DA Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]